Baseline characteristics of study population
| Patient characteristics | n (%) |
| Age | 61 (10) |
| BMI | 28 (5) |
| Cardiac risk factors | |
| Hypertension | 208 (50) |
| High cholesterol | 226 (54) |
| Diabetes mellitus | 121 (29) |
| Smoking | 74 (18) |
| Family history | 184 (44) |
| PTP | |
| Low (<10) | 58 (14) |
| Intermediate (10–90) | 328 (79) |
| High (>90) | 29 (7) |
| FRS | |
| Low | 208 (50) |
| Intermediate | 6 (2) |
| High | 201 (48) |
| Drugs | |
| Aspirin | 92 (22) |
| Statin | 143 (34) |
| BB | 37 (9) |
| ACEI/ARB | 125 (30) |
| CCB | 83 (20) |
ACEI, ACE inhibitor; ARB, angiotensin receptor blocker; BB, beta blocker; BMI, body mass index; CCB, calcium channel blocker; FRS, Framingham Risk Score; PTP, pretest probability.